Search by Medical Condition

A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

Clinical Trials for Ataxia

• To Evaluate the Effects of EryDex in Patients With A-T
• A Study of Omaveloxolone in Children With Friedreich's Ataxia
• A Safety and Pharmacokinetics Trial of VO659 in SCA1, SCA3 and HD
• Study to Evaluate Multiple Ascending Dose and Multi-Dose of DT-216 in Adult Patients With Friedreich Ataxia
• A Study to Assess the Safety and Efficacy of Vatiquinone in Participants With Friedreich Ataxia
• STRIDES - a Clinical Research Study of an Investigational New Drug to Treat Spinocerebellar Ataxia
• A Study of Vatiquinone for the Treatment of Participants With Friedreich Ataxia
• Phase IA Study of AAVrh.10hFXN Gene Therapy for the Cardiomyopathy of Friedreich's Ataxia
• Study to Evaluate DT-216 in Adult Patients With Friedreich Ataxia
• FRDA Investigator Initiated Study (IIS) With Elamipretide
• A Pharmacokinetics and Safety Study of BIIB132 in Adults With Spinocerebellar Ataxia 3
• Chinese Medicine WT for Spinocerebellar Ataxia Type 3
• Evaluation of the Effect of Artesunate in Friedreich Ataxia (FA)
• MBM-01 (Tempol) for the Treatment of Ataxia Telangiectasia
• NAD Supplementation to Prevent Progressive Neurological Disease in Ataxia Telangiectasia
• NAD+ Precursor Supplementation in Friedreich's Ataxia
• Evaluation of the Effects of Calcitriol's in the Neurological Symptoms of Friedreich's Ataxia Patients
• A Study to Assess the Efficacy and Safety of Vatiquinone for the Treatment of Participants With Friedreich Ataxia
• Study of CAD-1883 for Spinocerebellar Ataxia
• Safety and Efficacy of Etravirine in Friedreich Ataxia Patients
• C-Trelin Orally Disintegrated(OD) Tablet 5mg in Ataxia Due to Spinocerebellar Degeneration
• A Study to Assess Efficacy, Long Term Safety and Tolerability of RT001 in Subjects With Friedreich's Ataxia
• Micronised Resveratrol as a Treatment for Friedreich Ataxia
• Effect of Nilotinib in Cerebellar Ataxia Patients
• A Clinical Study to Evaluate the Effect of MIN-102 on the Progression of Friedreich's Ataxia in Male and Female Patients
• Tllsh2910 for Ataxia and Gut Microbiota Alteration in Patients of Multiple System Atrophy
• Open Trail of γIFN for Friedreich Ataxia
• Study of the Efficacy and Safety of Nicotinamide in Patients With Friedreich Ataxia
• N-Acetyl-L-Leucine for Ataxia-Telangiectasia (A-T)
• Troriluzole in Adult Subjects With Spinocerebellar Ataxia
• Baclofen/Diazepam Supps for Treatment of Pelvic Floor Myalgia
• An Open Pilot Trial of BHV-4157
• Clinical Trial With Riluzole in Spinocerebellar Ataxia Type 2 (ATRIL)
• Efficacy, Tolerability, and Pharmacokinetics of Multiple Doses of Oral TAK-831 in Adults With Friedreich Ataxia
• Trial in Adult Subjects With Spinocerebellar Ataxia
• A Clinical Trial of Dantrolene Sodium in Pediatric and Adult Patients With Wolfram Syndrome
• Long-Term Safety Extension Study of ACTIMMUNE® (Interferon γ-1b) in Children and Young Adults With Friedreich's Ataxia
• EDS in Ataxia Telangiectasia Patients
• Response of Individuals With Ataxia-Telangiectasia to Metformin and Pioglitazone
• Rosuvastatin (Crestor) in Friedreich Ataxia
• (+) Epicatechin to Treat Friedreich's Ataxia
• Treatment of Fragile-X Associated Tremor/Ataxia Syndrome (FXTAS) With Allopregnanolone
• Safety, Tolerability and Efficacy of ACTIMMUNE® Dose Escalation in Friedreich's Ataxia Study
• A TAK-831-1001, Single and Multiple Rising Dose Study in Healthy Participants
• A First in Human Study of RT001 in Patients With Friedreich's Ataxia
• Methylprednisolone Treatment of Friedreich Ataxia
• Safety, Tolerability and Efficacy of ACTIMMUNE® Dose Escalation in Friedreich's Ataxia
• Assess the Effect of Zolpidem, Silenor & Placebo on Arousability, Ataxia/Balance & Cognition in Healthy Volunteers
• An Open-label Trial of Intravenous Immune Globulin (IVIG)in Treating Spinocerebellar Ataxias
• RTA 408 Capsules in Patients With Friedreich's Ataxia - MOXIe
• Citocoline for Treatment of FXTAS
• A Phase IIa Trial to Test Safety and Efficacy Interferon Gamma Treatment in Elevating Frataxin Levels in FRDA Patients
• Interferon Gamma-1b in Friedreich Ataxia (FRDA)
• EPI-743 in Friedreich's Ataxia Point Mutations
• An Open-label Study of the Effects of Acetyl-L-Carnitine on Cardiovascular Outcomes in Friedreich's Ataxia
• Safety and Pharmacology Study of VP 20629 in Adults With Friedreich's Ataxia
• Dalfampridine and Gait in Spinocerebellar Ataxias
• Safety and Efficacy of EPI-743 in Patients With Friedreich's Ataxia
• An Objective Double-blind Evaluation of Bupropion and Citalopram in an Individual With Friedreich Ataxia
• 4-Aminopyridine in Episodic Ataxia Type 2
• Efficacy Study of Epoetin Alfa in Friedreich Ataxia
• A Study of Resveratrol as Treatment for Friedreich Ataxia
• Patient Reported Outcomes in Friedreich's Ataxia Patients After Withdrawal From Treatment With Idebenone (PROTI)
• Intra-Erythrocyte Dexamethasone Sodium Phosphate in Ataxia Teleangiectasia Patients
• Efficacy of Riluzole in Hereditary Cerebellar Ataxia
• Pilot Study of Safety and Efficacy of Sodium Phenylbutyrate in Spinocerebellar Ataxia Type 3
• Safety and Efficacy of Lithium Carbonate in Patients With Spinocerebellar Ataxia Type 3
• Status of Growth Hormone/ Insulin-like Growth Factor-1 (GH/IGF-1) Axis and Growth Failure in Ataxia Telangiectasia (AT)
• Safety and Efficacy Study of A0001 in Subjects With Friedreich's Ataxia
• Safety Study of Carbamylated Erythropoietin to Treat Patients With the Neurodegenerative Disorder Friedreich's Ataxia
• Safety and Tolerability of Lithium in Spinocerebellar Ataxia 2 (SCA2)
• Long-Term Safety and Tolerability of Idebenone in Friedreich's Ataxia Patients (MICONOS Extension)
• Study to Determine the Safety and Tolerability of Varenicline (Chantix®) in Treating Spinocerebellar Ataxia Type 3
• Coenzyme Q10 in Adult-Onset Ataxia
• Amantadine for Improving Neurologic Symptoms in Ataxia-Telangiectasia
• A Study of Efficacy, Safety and Tolerability of Idebenone in the Treatment of Friedreich's Ataxia (FRDA) Patients
• A Study Investigating the Long-term Safety and Efficacy of Deferiprone in Patients With Friedreich's Ataxia
• Efficacy of EGb761 in Patients Suffering From Friedreich Ataxia
• Effect of Pioglitazone Administered to Patients With Friedreich's Ataxia: Proof of Concept
• Pilot Study of Varenicline (Chantix®) in the Treatment of Friedreich's Ataxia
• Study to Assess the Safety and Tolerability of Idebenone in the Treatment of Friedreich's Ataxia Patients
• Lithium Treatment for Patients With Spinocerebellar Ataxia Type I
• Conjugate Pneumococcal Vaccine in Ataxia Telangiectasia (AT)
• Baclofen Treatment of Ataxia Telangiectasia
• Efficacy of Epoetin Alfa in Patients With Friedreich's Ataxia
• Memantine Treatment in Fragile X-Associated Tremor/Ataxia Syndrome
• Study to Assess the Efficacy, Safety and Tolerability of Idebenone in the Treatment of Friedreich's Ataxia
• A Study Investigating the Safety and Tolerability of Deferiprone in Patients With Friedreich's Ataxia
• Idebenone to Treat Friedreich's Ataxia
• Iron-Chelating Therapy and Friedreich Ataxia
• Effect of Riluzole as a Symptomatic Approach in Patients With Chronic Cerebellar Ataxia
• Study for Treatment of Cancer in Children With Ataxia-telangiectasia
• Phase 1 Trial of Idebenone to Treat Patients With Friedreich's Ataxia
• Safety Study of Idebenone to Treat Friedreich's Ataxia